<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37098006</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>27</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>05</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1545-7885</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>4</Issue><PubDate><Year>2023</Year><Month>Apr</Month></PubDate></JournalIssue><Title>PLoS biology</Title><ISOAbbreviation>PLoS Biol</ISOAbbreviation></Journal><ArticleTitle>Metabolic alterations of the immune system in the pathogenesis of autoimmune diseases.</ArticleTitle><Pagination><StartPage>e3002084</StartPage><MedlinePgn>e3002084</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e3002084</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pbio.3002084</ELocationID><Abstract><AbstractText>Systemic autoimmune diseases are characteristically associated with aberrant autoreactive innate and adaptive immune responses that lead to tissue damage and increased morbidity and mortality. Autoimmunity has been linked to alterations in the metabolic functions of immune cells (immunometabolism) and, more specifically, to mitochondrial dysfunction. Much has been written about immunometabolism in autoimmunity in general, so this Essay focuses on recent research into the role of mitochondrial dysfunction in the dysregulation of innate and adaptive immunity that is characteristic of systemic autoimmune diseases such as systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). Enhancing the understanding of mitochondrial dysregulation in autoimmunity will hopefully contribute to accelerating the development of immunomodulatory treatments for these challenging diseases.</AbstractText><CopyrightInformation>Copyright: This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Blanco</LastName><ForeName>Luz P</ForeName><Initials>LP</Initials><AffiliationInfo><Affiliation>Systemic Autoimmunity Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaplan</LastName><ForeName>Mariana J</ForeName><Initials>MJ</Initials><Identifier Source="ORCID">0000-0003-2968-0815</Identifier><AffiliationInfo><Affiliation>Systemic Autoimmunity Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>ZIA AR041199</GrantID><Acronym>ImNIH</Acronym><Agency>Intramural NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052060">Research Support, N.I.H., Intramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS Biol</MedlineTA><NlmUniqueID>101183755</NlmUniqueID><ISSNLinking>1544-9173</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001327" MajorTopicYN="Y">Autoimmune Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015551" MajorTopicYN="N">Autoimmunity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001172" MajorTopicYN="Y">Arthritis, Rheumatoid</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007107" MajorTopicYN="N">Immune System</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>27</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>25</Day><Hour>18</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>25</Day><Hour>13</Hour><Minute>33</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37098006</ArticleId><ArticleId IdType="pmc">PMC10128981</ArticleId><ArticleId IdType="doi">10.1371/journal.pbio.3002084</ArticleId><ArticleId IdType="pii">PBIOLOGY-D-22-02183</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ma L, Roach T, Morel L. Immunometabolic alterations in lupus: where do they come from and where do we go from there? Curr Opin Immunol. 2022;78:102245. doi: 10.1016/j.coi.2022.102245</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coi.2022.102245</ArticleId><ArticleId IdType="pubmed">36122544</ArticleId></ArticleIdList></Reference><Reference><Citation>Firestein GS, McInnes IB. Immunopathogenesis of Rheumatoid Arthritis. Immunity. 2017;46(2):183&#x2013;196. doi: 10.1016/j.immuni.2017.02.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2017.02.006</ArticleId><ArticleId IdType="pmc">PMC5385708</ArticleId><ArticleId IdType="pubmed">28228278</ArticleId></ArticleIdList></Reference><Reference><Citation>Britt EC, John SV, Locasale JW, Fan J. Metabolic regulation of epigenetic remodeling in immune cells. Curr Opin Biotechnol. 2020;63:111&#x2013;117. doi: 10.1016/j.copbio.2019.12.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.copbio.2019.12.008</ArticleId><ArticleId IdType="pmc">PMC7308195</ArticleId><ArticleId IdType="pubmed">31954223</ArticleId></ArticleIdList></Reference><Reference><Citation>Leinardi R, Longo Sanchez-Calero C, Huaux F. Think Beyond Particle Cytotoxicity: When Self-Cellular Components Released After Immunogenic Cell Death Explain Chronic Disease Development. Front Toxicol. 2022;4:887228. doi: 10.3389/ftox.2022.887228</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/ftox.2022.887228</ArticleId><ArticleId IdType="pmc">PMC9284505</ArticleId><ArticleId IdType="pubmed">35846433</ArticleId></ArticleIdList></Reference><Reference><Citation>James KD, Jenkinson WE, Anderson G. T-cell egress from the thymus: Should I stay or should I go? J Leukoc Biol. 2018;104(2):275&#x2013;284. doi: 10.1002/JLB.1MR1217-496R</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/JLB.1MR1217-496R</ArticleId><ArticleId IdType="pmc">PMC6174998</ArticleId><ArticleId IdType="pubmed">29485734</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xf3;mez-Ba&#xf1;uelos E, Konig MF, Andrade F. Microbial pathways to subvert host immunity generate citrullinated neoantigens targeted in rheumatoid arthritis. Curr Opin Struct Biol. 2022;75:102423. doi: 10.1016/j.sbi.2022.102423</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.sbi.2022.102423</ArticleId><ArticleId IdType="pmc">PMC9668488</ArticleId><ArticleId IdType="pubmed">35834948</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan S, Kotschenreuther K, Deng S, Kofler DM. Regulatory T cells in rheumatoid arthritis: functions, development, regulation, and therapeutic potential. Cell Mol Life Sci. 2022;79(10):533. doi: 10.1007/s00018-022-04563-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-022-04563-0</ArticleId><ArticleId IdType="pmc">PMC9522664</ArticleId><ArticleId IdType="pubmed">36173485</ArticleId></ArticleIdList></Reference><Reference><Citation>Farhangnia P, Akbarpour M. Immunological Tolerance. In: Rezaei N, editor. Encyclopedia of Infection and Immunity. Oxford: Elsevier; 2022. p. 206&#x2013;20.</Citation></Reference><Reference><Citation>Pulendran B, Arunachalam PS, O&#x2019;Hagan DT. Emerging concepts in the science of vaccine adjuvants. Nat Rev Drug Discov. 2021;20(6):454&#x2013;475. doi: 10.1038/s41573-021-00163-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41573-021-00163-y</ArticleId><ArticleId IdType="pmc">PMC8023785</ArticleId><ArticleId IdType="pubmed">33824489</ArticleId></ArticleIdList></Reference><Reference><Citation>Montgomery RA, Tatapudi VS, Leffell MS, Zachary AA. HLA in transplantation. Nat Rev Nephrol. 2018;14(9):558&#x2013;570. doi: 10.1038/s41581-018-0039-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41581-018-0039-x</ArticleId><ArticleId IdType="pubmed">29985463</ArticleId></ArticleIdList></Reference><Reference><Citation>Foong R-X, Santos AF. Oral Tolerance Induction&#x2014;Opportunities and Mechanisms. Foods. 2022;11(21):3386. doi: 10.3390/foods11213386</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/foods11213386</ArticleId><ArticleId IdType="pmc">PMC9654436</ArticleId><ArticleId IdType="pubmed">36360000</ArticleId></ArticleIdList></Reference><Reference><Citation>Faubert B, Solmonson A, DeBerardinis RJ. Metabolic reprogramming and cancer progression. Science. 2020;368(6487):eaaw5473. doi: 10.1126/science.aaw5473</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaw5473</ArticleId><ArticleId IdType="pmc">PMC7227780</ArticleId><ArticleId IdType="pubmed">32273439</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Gaber T. Hypoxia/HIF Modulates Immune Responses. Biomedicines. 2021;9:3. doi: 10.3390/biomedicines9030260</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines9030260</ArticleId><ArticleId IdType="pmc">PMC8000289</ArticleId><ArticleId IdType="pubmed">33808042</ArticleId></ArticleIdList></Reference><Reference><Citation>Spinelli JB, Rosen PC, Sprenger H-G, Puszynska AM, Mann JL, Roessler JM, et al.. Fumarate is a terminal electron acceptor in the mammalian electron transport chain. Science. 2021;374(6572):1227&#x2013;1237. doi: 10.1126/science.abi7495</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abi7495</ArticleId><ArticleId IdType="pmc">PMC8803114</ArticleId><ArticleId IdType="pubmed">34855504</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin M O &#x2019;Neill LAJ. The role of the electron transport chain in immunity. FASEB J. 2021;35(12):e21974.</Citation><ArticleIdList><ArticleId IdType="pubmed">34793601</ArticleId></ArticleIdList></Reference><Reference><Citation>Luengo A, Li Z, Gui DY, Sullivan LB, Zagorulya M, Do BT, et al.. Increased demand for NAD+ relative to ATP drives aerobic glycolysis. Mol Cell. 2021;81(4):691&#x2013;707.e6. doi: 10.1016/j.molcel.2020.12.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2020.12.012</ArticleId><ArticleId IdType="pmc">PMC8315838</ArticleId><ArticleId IdType="pubmed">33382985</ArticleId></ArticleIdList></Reference><Reference><Citation>Miglioranza Scavuzzi B, van Drongelen V, Kaur B, Fox JC, Liu J, Mesquita-Ferrari RA, et al.. The lupus susceptibility allele DRB1*03:01 encodes a disease-driving epitope. Commun Biol. 2022;5(1):751. doi: 10.1038/s42003-022-03717-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42003-022-03717-x</ArticleId><ArticleId IdType="pmc">PMC9334592</ArticleId><ArticleId IdType="pubmed">35902632</ArticleId></ArticleIdList></Reference><Reference><Citation>Lood C, Blanco LP, Purmalek MM, Carmona-Rivera C, De Ravin SS, Smith CK, et al.. Neutrophil extracellular traps enriched in oxidized mitochondrial DNA are interferogenic and contribute to lupus-like disease. Nat Med. 2016;22(2):146&#x2013;153. doi: 10.1038/nm.4027</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.4027</ArticleId><ArticleId IdType="pmc">PMC4742415</ArticleId><ArticleId IdType="pubmed">26779811</ArticleId></ArticleIdList></Reference><Reference><Citation>Blanco LP, Wang X, Carlucci PM, Torres-Ruiz JJ, Romo-Tena J, Sun H-W, et al.. RNA Externalized by Neutrophil Extracellular Traps Promotes Inflammatory Pathways in Endothelial Cells. Arthritis Rheumatol. 2021;73(12):2282&#x2013;2292. doi: 10.1002/art.41796</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.41796</ArticleId><ArticleId IdType="pmc">PMC8589882</ArticleId><ArticleId IdType="pubmed">33983685</ArticleId></ArticleIdList></Reference><Reference><Citation>Papayannopoulos V. Neutrophil extracellular traps in immunity and disease. Nat Rev Immunol. 2018;18(2):134&#x2013;147. doi: 10.1038/nri.2017.105</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri.2017.105</ArticleId><ArticleId IdType="pubmed">28990587</ArticleId></ArticleIdList></Reference><Reference><Citation>Dunham-Snary KJ, Surewaard BGJ, Mewburn JD, Bentley RET, Martin AY, Jones O, et al.. Mitochondria in human neutrophils mediate killing of Staphylococcus aureus. Redox Biol. 2022;49:102225. doi: 10.1016/j.redox.2021.102225</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.redox.2021.102225</ArticleId><ArticleId IdType="pmc">PMC8758915</ArticleId><ArticleId IdType="pubmed">34959099</ArticleId></ArticleIdList></Reference><Reference><Citation>Denny MF, Yalavarthi S, Zhao W, Thacker SG, Anderson M, Sandy AR, et al.. A Distinct Subset of Proinflammatory Neutrophils Isolated from Patients with Systemic Lupus Erythematosus Induces Vascular Damage and Synthesizes Type I IFNs. J Immunol. 2010;184(6):3284&#x2013;3297. doi: 10.4049/jimmunol.0902199</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.0902199</ArticleId><ArticleId IdType="pmc">PMC2929645</ArticleId><ArticleId IdType="pubmed">20164424</ArticleId></ArticleIdList></Reference><Reference><Citation>Villanueva E, Yalavarthi S, Berthier CC, Hodgin JB, Khandpur R, Lin AM, et al.. Netting Neutrophils Induce Endothelial Damage, Infiltrate Tissues, and Expose Immunostimulatory Molecules in Systemic Lupus Erythematosus. J Immunol. 2011;187(1):538&#x2013;552. doi: 10.4049/jimmunol.1100450</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1100450</ArticleId><ArticleId IdType="pmc">PMC3119769</ArticleId><ArticleId IdType="pubmed">21613614</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahman S, Sagar D, Hanna RN, Lightfoot YL, Mistry P, Smith CK, et al.. Low-density granulocytes activate T cells and demonstrate a non-suppressive role in systemic lupus erythematosus. Ann Rheum Dis. 2019;78(7):957&#x2013;966. doi: 10.1136/annrheumdis-2018-214620</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2018-214620</ArticleId><ArticleId IdType="pmc">PMC6585283</ArticleId><ArticleId IdType="pubmed">31040119</ArticleId></ArticleIdList></Reference><Reference><Citation>Duvvuri B, Baddour AA, Deane KD, Feser ML, Nelson JL, Demoruelle MK, et al.. Mitochondrial N-formyl methionine peptides associate with disease activity as well as contribute to neutrophil activation in patients with rheumatoid arthritis. J Autoimmun. 2021;119:102630. doi: 10.1016/j.jaut.2021.102630</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2021.102630</ArticleId><ArticleId IdType="pmc">PMC8062236</ArticleId><ArticleId IdType="pubmed">33713887</ArticleId></ArticleIdList></Reference><Reference><Citation>Li P, Jiang M, Li K, Li H, Zhou Y, Xiao X, et al.. Glutathione peroxidase 4&#x2013;regulated neutrophil ferroptosis induces systemic autoimmunity. Nat Immunol. 2021;22(9):1107&#x2013;1117. doi: 10.1038/s41590-021-00993-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-00993-3</ArticleId><ArticleId IdType="pmc">PMC8609402</ArticleId><ArticleId IdType="pubmed">34385713</ArticleId></ArticleIdList></Reference><Reference><Citation>Bock FJ, Tait SWG. Mitochondria as multifaceted regulators of cell death. Nat Rev Mol Cell Biol. 2020;21(2):85&#x2013;100. doi: 10.1038/s41580-019-0173-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41580-019-0173-8</ArticleId><ArticleId IdType="pubmed">31636403</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J, Gupta R, Blanco LP, Yang S, Shteinfer-Kuzmine A, Wang K, et al.. VDAC oligomers form mitochondrial pores to release mtDNA fragments and promote lupus-like disease. Science. 2019;366(6472):1531&#x2013;1536. doi: 10.1126/science.aav4011</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aav4011</ArticleId><ArticleId IdType="pmc">PMC8325171</ArticleId><ArticleId IdType="pubmed">31857488</ArticleId></ArticleIdList></Reference><Reference><Citation>Willson JA, Arienti S, Sadiku P, Reyes L, Coelho P, Morrison T, et al.. Neutrophil HIF-1&#x3b1; stabilization is augmented by mitochondrial ROS produced via the glycerol 3-phosphate shuttle. Blood. 2022;139(2):281&#x2013;286.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8832465</ArticleId><ArticleId IdType="pubmed">34411229</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaufman BA, Mora AL. IRGM1, a guardian of mitochondrial DAMP&#x2013;mediated autoinflammation. Nat Immunol. 2021;22(3):272&#x2013;273. doi: 10.1038/s41590-021-00877-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-00877-6</ArticleId><ArticleId IdType="pmc">PMC8607984</ArticleId><ArticleId IdType="pubmed">33547457</ArticleId></ArticleIdList></Reference><Reference><Citation>Rai P, Janardhan KS, Meacham J, Madenspacher JH, Lin W-C, Karmaus PWF, et al.. IRGM1 links mitochondrial quality control to autoimmunity. Nat Immunol. 2021;22(3):312&#x2013;321. doi: 10.1038/s41590-020-00859-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-020-00859-0</ArticleId><ArticleId IdType="pmc">PMC7906953</ArticleId><ArticleId IdType="pubmed">33510463</ArticleId></ArticleIdList></Reference><Reference><Citation>Caielli S, Cardenas J, de Jesus AA, Baisch J, Walters L, Blanck JP, et al.. Erythroid mitochondrial retention triggers myeloid-dependent type I interferon in human SLE. Cell. 2021;184(17):4464&#x2013;79.e19. doi: 10.1016/j.cell.2021.07.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.07.021</ArticleId><ArticleId IdType="pmc">PMC8380737</ArticleId><ArticleId IdType="pubmed">34384544</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho J-A, Kim T-J, Moon H-J, Kim Y-J, Yoon H-K, Seong S-Y. Cardiolipin activates antigen-presenting cells via TLR2-PI3K-PKN1-AKT/p38-NF-kB signaling to prime antigen-specific na&#xef;ve T cells in mice. Eur J Immunol. 2018;48(5):777&#x2013;790.</Citation><ArticleIdList><ArticleId IdType="pubmed">29313959</ArticleId></ArticleIdList></Reference><Reference><Citation>You R, He X, Zeng Z, Zhan Y, Xiao Y, Xiao R. Pyroptosis and Its Role in Autoimmune Disease: A Potential Therapeutic Target. Front Immunol. 2022;13:841732. doi: 10.3389/fimmu.2022.841732</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.841732</ArticleId><ArticleId IdType="pmc">PMC9174462</ArticleId><ArticleId IdType="pubmed">35693810</ArticleId></ArticleIdList></Reference><Reference><Citation>Kahlenberg JM, Kaplan MJ. The inflammasome and lupus: another innate immune mechanism contributing to disease pathogenesis? Curr Opin Rheumatol. 2014;26(5):475&#x2013;481. doi: 10.1097/BOR.0000000000000088</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BOR.0000000000000088</ArticleId><ArticleId IdType="pmc">PMC4153426</ArticleId><ArticleId IdType="pubmed">24992143</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu J, Singh K, Lin A, Meadows AM, Wu K, Shing V, et al.. Boosting NAD+ blunts TLR4-induced type I IFN in control and systemic lupus erythematosus monocytes. J Clin Investig. 2022;132(5):e139828. doi: 10.1172/JCI139828</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI139828</ArticleId><ArticleId IdType="pmc">PMC8884917</ArticleId><ArticleId IdType="pubmed">35025762</ArticleId></ArticleIdList></Reference><Reference><Citation>Gkirtzimanaki K, Kabrani E, Nikoleri D, Polyzos A, Blanas A, Sidiropoulos P, et al.. IFN&#x3b1; Impairs Autophagic Degradation of mtDNA Promoting Autoreactivity of SLE Monocytes in a STING-Dependent Fashion. Cell Rep. 2018;25(4):921&#x2013;33.e5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6218203</ArticleId><ArticleId IdType="pubmed">30355498</ArticleId></ArticleIdList></Reference><Reference><Citation>Reglero-Real N, P&#xe9;rez-Guti&#xe9;rrez L, Nourshargh S. Endothelial cell autophagy keeps neutrophil trafficking under control. Autophagy. 2021;17(12):4509&#x2013;4511. doi: 10.1080/15548627.2021.1987675</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2021.1987675</ArticleId><ArticleId IdType="pmc">PMC8726622</ArticleId><ArticleId IdType="pubmed">34720030</ArticleId></ArticleIdList></Reference><Reference><Citation>Sumikawa MH, Iwata S, Zhang M, Miyata H, Ueno M, Todoroki Y, et al.. An enhanced mitochondrial function through glutamine metabolism in plasmablast differentiation in systemic lupus erythematosus. Rheumatology. 2021;61(7):3049&#x2013;3059.</Citation><ArticleIdList><ArticleId IdType="pubmed">34730825</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeshima Y, Iwasaki Y, Nakano M, Narushima Y, Ota M, Nagafuchi Y, et al.. Immune cell multiomics analysis reveals contribution of oxidative phosphorylation to B-cell functions and organ damage of lupus. Ann Rheum Dis. 2022;81(6):845&#x2013;853. doi: 10.1136/annrheumdis-2021-221464</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2021-221464</ArticleId><ArticleId IdType="pubmed">35236659</ArticleId></ArticleIdList></Reference><Reference><Citation>Zegallai HM, Abu-El-Rub E, Cole LK, Field J, Mejia EM, Gordon JW, et al.. Tafazzin deficiency impairs mitochondrial metabolism and function of lipopolysaccharide activated B lymphocytes in mice. FASEB J. 2021;35(12):e22023. doi: 10.1096/fj.202100811RR</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.202100811RR</ArticleId><ArticleId IdType="pubmed">34767647</ArticleId></ArticleIdList></Reference><Reference><Citation>Becker YLC, Gagn&#xe9; JP, Julien AS, L&#xe9;vesque T, Allaeys I, Gougeard N, et al.. Identification of Mitofusin 1 and Complement Component 1q Subcomponent Binding Protein as Mitochondrial Targets in Systemic Lupus Erythematosus. Arthritis Rheumatol. 2022;74(7):1193&#x2013;1203. doi: 10.1002/art.42082</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.42082</ArticleId><ArticleId IdType="pubmed">35128841</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L, Duvvuri B, Grigull J, Jamnik R, Wither JE, Wu GE. Experimental evidence that mutated-self peptides derived from mitochondrial DNA somatic mutations have the potential to trigger autoimmunity. Hum Immunol. 2014;75(8):873&#x2013;879. doi: 10.1016/j.humimm.2014.06.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.humimm.2014.06.012</ArticleId><ArticleId IdType="pubmed">24979674</ArticleId></ArticleIdList></Reference><Reference><Citation>Buskiewicz IA, Montgomery T, Yasewicz EC, Huber SA, Murphy MP, Hartley RC, et al.. Reactive oxygen species induce virus-independent MAVS oligomerization in systemic lupus erythematosus. Sci Signal. 2016;9(456):ra115&#x2013;ra. doi: 10.1126/scisignal.aaf1933</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scisignal.aaf1933</ArticleId><ArticleId IdType="pmc">PMC5321043</ArticleId><ArticleId IdType="pubmed">27899525</ArticleId></ArticleIdList></Reference><Reference><Citation>Caza TN, Talaber G, Perl A. Metabolic regulation of organelle homeostasis in lupus T cells. Clin Immunol. 2012;144(3):200&#x2013;213. doi: 10.1016/j.clim.2012.07.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2012.07.001</ArticleId><ArticleId IdType="pmc">PMC3423541</ArticleId><ArticleId IdType="pubmed">22836085</ArticleId></ArticleIdList></Reference><Reference><Citation>Mok A, Solomon O, Nayak RR, Coit P, Quach HL, Nititham J, et al.. Genome-wide profiling identifies associations between lupus nephritis and differential methylation of genes regulating tissue hypoxia and type 1 interferon responses. Lupus Sci Med. 2016;3(1):e000183. doi: 10.1136/lupus-2016-000183</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/lupus-2016-000183</ArticleId><ArticleId IdType="pmc">PMC5174796</ArticleId><ArticleId IdType="pubmed">28074145</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen P-M, Wilson PC, Shyer JA, Veselits M, Steach HR, Cui C, et al.. Kidney tissue hypoxia dictates T cell-mediated injury in murine lupus nephritis. Sci Transl Med. 2020;12(538):eaay1620. doi: 10.1126/scitranslmed.aay1620</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aay1620</ArticleId><ArticleId IdType="pmc">PMC8055156</ArticleId><ArticleId IdType="pubmed">32269165</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu B, Zhao TV, Jin K, Hu Z, Abdel MP, Warrington KJ, et al.. Mitochondrial aspartate regulates TNF biogenesis and autoimmune tissue inflammation. Nat Immunol. 2021;22(12):1551&#x2013;1562. doi: 10.1038/s41590-021-01065-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01065-2</ArticleId><ArticleId IdType="pmc">PMC8756813</ArticleId><ArticleId IdType="pubmed">34811544</ArticleId></ArticleIdList></Reference><Reference><Citation>Almeida L, Dhillon-LaBrooy A, Castro CN, Adossa N, Carriche GM, Guderian M, et al.. Ribosome-Targeting Antibiotics Impair T Cell Effector Function and Ameliorate Autoimmunity by Blocking Mitochondrial Protein Synthesis. Immunity. 2021;54(1):68&#x2013;83.e6. doi: 10.1016/j.immuni.2020.11.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2020.11.001</ArticleId><ArticleId IdType="pmc">PMC7837214</ArticleId><ArticleId IdType="pubmed">33238133</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu Y, Zhang X, Xie S, Bao W, Chen J, Wu Q, et al.. Oxidative phosphorylation regulates interleukin-10 production in regulatory B cells via the extracellular signal-related kinase pathway. Immunology. 2022;167(4):576&#x2013;589. doi: 10.1111/imm.13554</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imm.13554</ArticleId><ArticleId IdType="pubmed">35899990</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia M, Zhang C, Chen Y, Zhao X, Zhang S, Liu Y, et al.. Transcription factor EB coordinates environmental cues to regulate T regulatory cells&#x2019; mitochondrial fitness and function. Proc Natl Acad Sci U S A. 2022;119(31):e2205469119. doi: 10.1073/pnas.2205469119</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2205469119</ArticleId><ArticleId IdType="pmc">PMC9351480</ArticleId><ArticleId IdType="pubmed">35895684</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W, Gong M, Park YP, Elshikha AS, Choi S-C, Brown J, et al.. Lupus susceptibility gene Esrrg modulates regulatory T cells through mitochondrial metabolism. JCI Insight. 2021;6(14):e143540. doi: 10.1172/jci.insight.143540</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.143540</ArticleId><ArticleId IdType="pmc">PMC8410062</ArticleId><ArticleId IdType="pubmed">34156979</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu B, Qiu J, Zhao TV, Wang Y, Maeda T, Goronzy IN, et al.. Succinyl-CoA Ligase Deficiency in Pro-inflammatory and Tissue-Invasive T Cells. Cell Metab. 2020;32(6):967&#x2013;80.e5. doi: 10.1016/j.cmet.2020.10.025</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2020.10.025</ArticleId><ArticleId IdType="pmc">PMC7755381</ArticleId><ArticleId IdType="pubmed">33264602</ArticleId></ArticleIdList></Reference><Reference><Citation>Blanco LP, Pedersen HL, Wang X, Lightfoot YL, Seto N, Carmona-Rivera C, et al.. Improved Mitochondrial Metabolism and Reduced Inflammation Following Attenuation of Murine Lupus With Coenzyme Q10 Analog Idebenone. Arthritis Rheumatol. 2020;72(3):454&#x2013;464. doi: 10.1002/art.41128</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.41128</ArticleId><ArticleId IdType="pmc">PMC7050361</ArticleId><ArticleId IdType="pubmed">31566908</ArticleId></ArticleIdList></Reference><Reference><Citation>Fortner KA, Blanco LP, Buskiewicz I, Huang N, Gibson PC, Cook DL, et al.. Targeting mitochondrial oxidative stress with MitoQ reduces NET formation and kidney disease in lupus-prone MRL-lpr mice. Lupus Sci Med. 2020;7(1):e000387. doi: 10.1136/lupus-2020-000387</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/lupus-2020-000387</ArticleId><ArticleId IdType="pmc">PMC7199895</ArticleId><ArticleId IdType="pubmed">32343673</ArticleId></ArticleIdList></Reference><Reference><Citation>Peace CG O &#x2019;Neill LA. The role of itaconate in host defense and inflammation. J Clin Invest. 2022;132(2).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8759771</ArticleId><ArticleId IdType="pubmed">35040439</ArticleId></ArticleIdList></Reference><Reference><Citation>Blanco LP, Patino-Martinez E, Nakabo S, Zhang M, Pedersen HL, Wang X, et al.. Modulation of the Itaconate Pathway Attenuates Murine Lupus. Arthritis Rheumatol. 2022;74(12):1971&#x2013;1983. doi: 10.1002/art.42284</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.42284</ArticleId><ArticleId IdType="pubmed">35791960</ArticleId></ArticleIdList></Reference><Reference><Citation>Tumurkhuu G, Chen S, Montano EN, Ercan Laguna D, De Los SG, Yu JM, et al.. Oxidative DNA Damage Accelerates Skin Inflammation in Pristane-Induced Lupus Model. Front Immunol. 2020;11:554725. doi: 10.3389/fimmu.2020.554725</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.554725</ArticleId><ArticleId IdType="pmc">PMC7541920</ArticleId><ArticleId IdType="pubmed">33072095</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson CS, Stocks BT, Hoopes EM, Rhoads JP, McNew KL, Major AS, et al.. Metabolic preconditioning in CD4+ T cells restores inducible immune tolerance in lupus-prone mice. JCI Insight. 2021;6(19):e143245. doi: 10.1172/jci.insight.143245</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.143245</ArticleId><ArticleId IdType="pmc">PMC8525586</ArticleId><ArticleId IdType="pubmed">34403367</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan SY, Kelkar Y, Hadjipanayis A, Shipstone A, Wynn TA, Hall JP. Metformin and 2-Deoxyglucose Collaboratively Suppress Human CD4+ T Cell Effector Functions and Activation-Induced Metabolic Reprogramming. J Immunol. 2020;205(4):957&#x2013;967. doi: 10.4049/jimmunol.2000137</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.2000137</ArticleId><ArticleId IdType="pubmed">32641388</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>